招募中 NCT05761093

香港mPC治疗的患者与医生获益/风险偏好:一项离散选择实验

前列腺癌不适用III 期IV 期

本研究旨在检视来自不同疾病阶段的医生及前列腺癌患者对治疗风险/获益属性的偏好权重。

适应症:Prostate Cancer

入组条件

纳入标准

  • aged 18 years or older,
  • diagnosis of metastatic prostate cancer within 5 years,
  • able to read and write,
  • accepting and signing the informed consent

排除标准

  • if patients are unable to complete the survey by themselves due to physical or psychological reasons,
  • deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons,
  • deemed ineligible by treating physicians

入组条件维持 ClinicalTrials.gov 原始英文登记资料,实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源:ClinicalTrials.gov,每两周自动更新,最后同步:2026年10月8日。